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Association between oxidative stress biomarkers  
and concentrations of some metal ions in the blood  
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A b s t r a c t
Introduction: Any substance that induces production of free radicals can be 
a potential cause of brain damage. The aim of our study was to investigate 
the relationship between some metal ions and oxidative stress biomarkers 
in the blood of patients with brain tumor and hydrocephalus. 
Material and methods: Our study included 27 control subjects, 24 patients 
with brain tumor and 21 patients with hydrocephalus. The activities of 
superoxide dismutase (CuZn SOD), catalase (CAT), glutathione peroxidase 
(GSH-Px), glutathione reductase (GR), glutathione S-transferase (GST) and 
acetyl cholinesterase (AChE), as well as concentrations of reduced glutathi-
one (GSH), lipid peroxides (TBARS) and sulfhydryl groups (SH) were analyzed 
in the plasma and red blood cells (RBCs) of patients. We also determined the 
concentrations of Mn, Ni, Co, Cu, Zn, As, Se, Cd, Hg and Fe. 
Results: The higher activity of SOD and concentration of GSH in both in-
vestigated groups could indicate higher oxidative stress. We also observed 
decreased levels of SH groups in both groups of patients. In both groups of 
patients we detected decreased concentrations of Ni, Co, Zn and Fe (and Mn 
in brain tumor patients) and increased concentrations of As, Se and Cd in 
the blood. Interestingly, we observed a higher concentration of Cd in both 
plasma and RBCs of hydrocephalus patients compared to the patients with 
brain tumor. 
Conclusions: There are strong correlations between some metal ion concen-
trations and certain oxidative stress biomarkers in the blood of patients, 
which supports our hypothesis, but the observed trend needs to be further 
investigated.
Key words: antioxidant enzymes, trace elements, neurotoxicity redox 
homeostasis.
Introduction
Oxygen is an inevitable component of aerobic life. Incomplete reduc-
tion of oxygen to water during normal aerobic metabolism generates 
reactive oxygen species (ROS), which have one or more unpaired elec-
trons. ROS, such as superoxide anion, singlet oxygen, hydroxyl radical 
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and hydrogen peroxide, play an important role in 
many pathophysiological processes. ROS are also 
involved in oncogenes, oxidative stress and cellu-
lar differentiation [1]. Oxidative stress is defined 
as an imbalance between the production and 
removal of ROS. The cellular antioxidant defense 
protects cells against ROS and includes enzymes, 
such as superoxide dismutases (SODs), catalase 
(CAT), glutathione peroxidases (GSH-Px), gluta-
thione reductase (GR) and glutathione S-transfer-
ase (GST), as well as non-enzymatic antioxidants, 
such as glutathione (GSH) [1]. 
Many studies have reported toxic and carcino-
genic effects induced by certain metal ions. It is 
also known that some essential transition metal 
ions (zinc, iron, copper, cobalt and manganese) 
participate in the control of various metabolic and 
signaling pathways. A complex balance of trace 
elements is crucial for all areas of maintaining hu-
man health, preventing health problems and over-
coming them [2]. Trace elements are important for 
development of the nervous system, myelination 
of nerve fibers and neuronal excitability [3]. For 
normal trace element homeostasis in the brain 
the blood-brain barrier plays an important role [4]. 
The brain represents 2% of the total body, but 
utilizes 20% of oxygen consumed by the body, in-
dicating that the brain can be a source of many 
more free radicals than the other body tissues [5]. 
Oxidative damage has long been implicated in the 
process of carcinogenesis, as well as in the degree 
of malignant transformation of most types of tu-
mors [4]. Hydrocephalus represents an abnormal 
accumulation of cerebrospinal fluid (CSF) with-
in or around the brain, due to obstruction of CSF 
flow, inadequate CSF absorption and/or excessive 
CSF production. Untreated hydrocephalus can lead 
to ventricular dilatation and increased intracranial 
pressure, potentially causing an enlarged cranium 
(in children), brain atrophy, neuronal deficits and 
eventually death [6]. Abnormal metabolism of metal 
ions (known to participate in oxidative cascades) is 
associated with hydrocephalus in farm animals [7]. 
There are only a few reports on the involvement 
of ROS in the development of brain tumors and 
hydrocephalus in correlations with some metal 
ion concentrations. Thus, the aim of the present 
study was to investigate the possible relation-
ship between oxidative stress biomarkers and 
some metal ions in the blood of patients with 
brain tumors and hydrocephalus. We investigated 
the activity of the following antioxidant defense 
enzymes: copper and zinc-containing superox-
ide-dismutase (CuZn SOD, EC 1.15.1.1), catalase 
(CAT, EC 1.11.1.6), glutathione peroxidase (GSH-
Px, EC 1.11.1.9) and glutathione reductase (GR, EC 
1.6.4.2) in red blood cells (RBCs), and activity of 
glutathione S-transferase (GST, EC 2.5.1.18) in the 
plasma. We also determined plasma total glutathi-
one content (GSH) and concentration of sulfhydryl 
groups (SH). As an indicator of lipid modification, 
we measured plasma lipid peroxide concentration 
(TBARS) and acetylcholine esterase activity (AChE, 
EC 3.1.1.7) as biomarkers of neurotoxicity. 
Material and methods
Subjects
In our study, we used blood samples obtained 
from clinically healthy persons (control group), pa-
tients with various forms of malignant brain tu-
mors and patients suffering from hydrocephalus. 
All brain damage was confirmed clinically, histo-
logically or using magnetic resonance.
Blood samples of 27 healthy control subjects 
(mean age: 47 ±3 years; sex ratio m/f = 14/13) 
were used in our experiments. Blood samples were 
also obtained from 45 patients with intracranial tu-
mors (mean age: 41 ±6 years; sex ratio m/f = 15/9) 
and hydrocephalus (mean age: 43 ±5; sex ratio m/f 
= 13/8). Several types of malignant tumors were 
included in our study: 17 glioblastoma multiforme 
WHO grade IV (GBM), two medulloblastoma WHO 
grade IV, two atypical teratoid rhabdoid tumor 
(ATRTs), one meningioma atypicum WHO grade II 
and two secondary-metastatic tumors (melanoma, 
carcinoma). All the tumors were classified accord-
ing to the criteria of the WHO [8].
The exclusion criteria in the study were viral 
infections, dietary supplements and smoking. 
The study was conducted in full compliance with 
principles of the World Medical Association Dec-
laration of Helsinki “Ethical Principles for Medical 
Research Involving Human Subjects” (Helsinki, 
1964, as amended during 1975–2000); and cur-
rent legislative and government regulations of the 
Republic of Serbia. The study has been approved 
by the Ethics Committee of the Clinical Center of 
Serbia Belgrade. Blood samples were taken from 
all subjects only after obtaining written informed 
consent for participation in the study. All data and 
the personal information collected in this study 
are subject to medical confidentiality and may 
only be brought together for processing and eval-
uation in an anonymous form. 
Blood sampling and biochemical 
procedures
Each participant donated a 5 ml blood sample. 
Lithium-heparin was used as an anticoagulant. 
Immediately after collection, blood samples were 
centrifuged at 5000 rpm for 15 min in order to 
separate plasma and RBCs.
Oxidative stress biomarkers were assessed im-
mediately after blood collection in order to avoid 
any possible modification of the results caused by 
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storage [9]. Activities of CuZn SOD, CAT, GSH-Px 
and GR were determined in the RBCs, while activi-
ties of GST and AChE, as well as concentrations of 
total GSH, SH groups and lipid peroxides (TBARS) 
were determined in the plasma.
GST activity in the plasma towards 1-chloro- 
2,4-dinitrobenzene (CDNB) as a substrate was 
measured as described by Habig et al. [10] and ex-
pressed as nmol GSH/min/ml of plasma. GSH con-
centration was determined in the plasma accord-
ing to the method of Griffith [11] and expressed 
as nmol/l plasma. The concentration of SH groups 
was determined in the plasma according to the 
method of Ellman [12] and expressed as μmol/ ml 
of plasma. AChE activity was determined spectro-
photometrically at 412 nm in the plasma accord-
ing to the Ellman et al. [13] method. AChE activi-
ty was expressed as μmol/min/l plasma. Plasma 
lipid peroxidation was measured by the thiobar-
bituric acid reaction according to the method of 
Ohkawa et al. [14] at 532 nm and expressed as 
nmol TBARS/ml of blood. 
Isolated RBCs were washed three times with 
2 volumes of isotonic 0.9% NaCl. The hemoglobin 
(Hb) concentration in RBCs (g Hb/100 ml) was es-
timated by the cyanmethemoglobin method [15] 
and used for calculating enzyme activities. CuZn 
SOD activity was measured in the RBCs from 
which Hb was previously removed by the method 
of Tsuchihashi [16]. CuZn SOD activity was mea-
sured by the epinephrine method [17] and one 
unit of SOD activity was defined as the amount of 
enzyme that caused 50% inhibition of the autox-
idation of adrenaline to adrenochrome. CAT activ-
ity was determined according to Beutler [18] and 
expressed as mmol H
2O2/min/g Hb. In accordance 
with [19], hemolysates containing about 50 g Hb/l 
were used for the determination of GSH-Px activ-
ity [20]. GSH-Px activity was expressed as nmol 
NADPH/min/g Hb. The activity of GR was estimat-
ed by measuring NADPH oxidation at 340 nm [21] 
and expressed as nmol NADPH/min/g Hb. 
The oxidative stress biomarkers were measured 
simultaneously in triplicate for each sample, using 
a Shimadzu UV-1800 spectrophotometer with 
a temperature-controlled cuvette holder. All chem-
icals were purchased from Sigma-Aldrich (Saint 
Louis, MO, USA) or Merck (Darmstadt, Germany).
Metal analysis 
The concentrations of nine elements (Mn, Ni, 
Co, Cu, Zn, As, Se, Cd, and Hg) were determined 
by inductively coupled plasma-mass spectrometry, 
ICP-MS (ICAP Q, Thermo Scientific X series 2). The 
entire system was controlled with the Qtegra In-
strument Control Software. 
The iron was determined by ICP-optical emis-
sion spectroscopy, ICP-OES (model 6500 Duo, 
Thermo Scientific, UK). The entire system was 
controlled with the iTEVA software. 
Sample preparation
Plasma and RBCs were transferred into PTFE 
cuvettes and measured. Four milliliters of 65% ni-
tric acid and 1 ml of 30% hydrogen peroxide were 
added to each PTFE cuvette and digestion was 
performed under the following program: warm up 
for 2 min to 85°C, 4 min to 135°C, 5 min to 230°C 
and held for 15 min at that temperature. After 
cooling samples were quantitatively transferred 
into volumetric flask (10 ml) and diluted with dis-
tilled water. 
Statistical analysis
The data were expressed as mean ± SE. The 
degree for statistical significance was defined as 
p < 0.05. Data were checked for normality using 
the Kolmogorov-Smirnov test. Differences in in-
vestigated parameters between groups were cal-
culated using one-way ANOVA. Post hoc pair-wise 
comparisons were performed using the Tukey 
HSD test. Principal component analysis (PCA) was 
implemented to statistically determine the differ-
ences between investigated groups based on all 
investigated oxidative stress biomarkers. Data 
considering metal concentrations were analyzed 
by the Mann-Whitney U test and expressed as 
mean ± SD. Relationships among the analyzed 
parameters were investigated using Pearson’s 
correlation coefficients. The statistical package 
Statistica 10.0 was used for all analyses.
Results
The activity of CuZn SOD in RBCs (Figure 1) was 
significantly higher in both brain tumor and hy-
drocephalus groups compared to the control indi-
viduals (p < 0.05). 
However, the activities of CAT, GSH-Px and GST 
(Figure 1) were not significantly different in the 
investigated groups when compared to the con-
trols. On the other hand, GSH concentration (Fig-
ure 2) was significantly higher in both the brain 
tumor and the hydrocephalus groups (p < 0.05). 
Significantly higher AChE activity (Figure 2) was 
observed in hydrocephalus patients when com-
pared to both the controls and the brain tumor 
group (p < 0.05). Significantly lower concentra-
tion of SH groups (Figure 2) was detected in both 
the brain tumor and the hydrocephalus groups 
(p < 0.05) when compared to the control individuals. 
Principal component analysis (PCA) was em-
ployed to detect a possible separation of all three 
examined groups of individuals based on over-
all investigated oxidative stress biomarkers. The 
summary results of PCA for all three investigated 
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groups of patients are presented in Figure 3 and 
indicate that factor 1 and factor 2 explain 100% of 
the total variance. Factor 1 (86%) clearly discrim-
inates healthy (control) and sick (brain tumors 
and hydrocephalus) individuals. Factor 2 (14%) 
distinctly discriminates control and hydrocephalus 
groups from brain tumor patients. 
Metal concentrations are presented in Table I. 
Ten metal ions (Mn, Ni, Co, Cu, Zn, As, Se, Cd, Hg, 
and Fe) were quantified in each sample of plas-
ma and RBC hemolysates. Statistically significant 
differences in the concentration of metal ions in 
the plasma were obtained for the following met-
al ions: Mn, Ni, Co, Zn, As, Cd and Fe. Our results 
show lower concentrations of Mn, Ni and Zn in the 
plasma and Ni, Co and Fe in RBCs of brain tumor 
patients in comparison to the control group (p < 
0.05). In RBCs of brain tumor patients, higher con-
centrations of As, Se and Cd were observed. In pa-
tients with hydrocephalus we detected decreased 
concentrations of Ni, Co, Zn and Fe in the plas-
ma, as well as Ni and Fe in RBCs also. Increased 
concentrations of As, Se and Cd were measured 
in RBCs (As and Cd in the plasma) of same group 
of patients (Table I). Interestingly, there are higher 
concentrations of Cd in both plasma and RBCs of 
hydrocephalus patients when compared with pa-
tients with brain tumor (p < 0.05).
Statistically significant Pearson’s correlations 
between oxidative stress biomarkers as well as 
AChE activity and metal ions in the plasma and 
RBC hemolysate of patients with brain tumors 
and hydrocephalus, in relation to the controls are 
presented in Tables II and III. The data obtained 
for oxidative stress parameters determined in the 
plasma (GST, GSH, SH groups, LP) and for AChE 
activity were compared with the plasma metal 
concentrations, while data for oxidative stress pa-
rameters obtained in RBCs (CuZn SOD, CAT, GSH-
Px and GR) were compared with metal concentra-
tions detected in RBCs.
The Pearson’s correlation coefficients of inves-
tigated oxidative stress parameters and metal 
ions in plasma are presented in Table II. In patients 
with brain tumors, positive correlations were ob-
tained for Co and Cd with SH groups, as well as 
Figure 1. Oxidative stress biomarkers in the plasma 
and RBC hemolysates of the control group and pa-
tients with brain tumors and hydrocephalus
The data are expressed as mean ± SE. One-way ANOVA 
and Tukey HSD test were used. P < 0.05 was accepted as 
significant (a – brain tumor vs. control, b – hydrocephalus 
vs. control, c – brain tumor vs. hydrocephalus).
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for Hg and AChE activity. There are some positive 
correlations in the plasma of patients with hydro-
cephalus: Mn and Fe with GST, as well as Co and 
Zn with SH groups. Only one negative correlation 
was obtained for Co and AChE activity.
The obtained correlation coefficients of inves-
tigated parameters and metal ions in RBCs are 
presented in Table III. In patients with brain tu-
mors, GSH-Px also correlated with Cu and Se. In 
the same group of patients, negative correlations 
were obtained between CuZn SOD and Hg, as well 
as between CAT and Cu and Se. In patients with 
hydrocephalus, SOD correlated positively with Se, 
and negatively with Ni, Cu, Cd and Hg.
Discussion
The complex series of cellular and molecular 
changes that occur through the development of 
cancer can be mediated by a diversity of endoge-
nous and environmental stimuli. The human brain 
is especially vulnerable to free radical attack be-
cause of its high oxygen consumption and high 
concentrations of easily oxidizable polyunsaturat-
ed fatty acids. In addition, the brain’s antioxidant 
capacity is lower compared with other organs, and 
thus the brain may be more susceptible to oxida-
tive damage [22]. 
Increased oxidative stress was considered to 
have some role in the pathogenesis of various dis-
eases [23]. Cancer in its complex pathology can 
be considered both a cause and a consequence of 
oxidative stress. Moreover, carcinogenic activities 
of substances that act as tumor promoters are 
associated with weakening of the cellular antiox-
idant defense system and decrease in some of its 
constituents [24]. The best solution in the process 
of brain tumor diagnosis could be readily available 
biomarkers that should be useful in the monitor-
ing of the disease course, differential diagnosis 
and planning surgical intervention [25].
Figure 2. Oxidative stress biomarkers in the plasma and RBC hemolysates of the control group and patients with 
brain tumors and hydrocephalus
The data are expressed as mean ± SE. One-way ANOVA and Tukey HSD test were used. P < 0.05 was accepted as significant.  
(a – brain tumor vs. control, b – hydrocephalus vs. control, c – brain tumor vs. hydrocephalus).
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Figure 3. Principal component analysis (PCA) of all 
investigated oxidative stress biomarkers of each 
investigated group of individuals (Control, Brain tu-
mor and Hydrocephalus) on the factor plane
Projection of the cases on the factor-plane (1 × 2). Cases 
with sum of cosine square ≥ 0.00.
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Table I. Concentrations of selected metal ions (ng/g and μg/g) in the plasma and RBCs of the control group and 
patients with brain tumors and hydrocephalus
Parameter Control Brain tumor Hydrocephalus
Mn [ng/g] Plasma 7.14 ±6.45 3.55 ±2.36a 5.64 ±4.54
RBCs 3.86 ±2.83 4.48 ±4.07 4.74 ±4.64
Ni [ng/g] Plasma 6.75 ±2.35 4.44 ±2.56a 4.53 ±2.87b
RBCs 3.12 ±1.02 1.73 ±1.27a 1.59 ±1.32b
Co [ng/g] Plasma 0.80 ±0.56 0.58 ±0.53 0.42 ±0.55 b
RBCs 0.31 ±0.27 0.20 ±0.47a 0.32 ±0.54
Cu [μg/g] Plasma 1.22 ±0.38 1.15 ±0.27 1.08 ±0.24
RBCs 0.10 ±0.02 0.10 ±0.04 0.09 ±0.02
Zn [μg/g] Plasma 0.63 ±0.13 0.49 ±0.18a 0.57 ±0.17b
RBCs 1.35 ±0.45 1.50 ±0.55 1.42 ±0.28
As [ng/g] Plasma 1.54 ±0.58 1.77 ±0.55 1.91 ±0.79b
RBCs 0.05 ±0.03 0.26 ±0.23a 0.21 ±0.19b
Se [ng/g] Plasma 83.17 ±21.59 74.18 ±24.76 73.86 ±20.89
RBCs 9.01 ±5.19 15.09 ±9.53a 14.24 ±6.65b
Cd [ng/g] Plasma 0.01 ±0.00 0.02 ±0.02 0.05 ±0.02bc
RBCs 0.01 ±0.00 0.10 ±0.27a 0.21 ±0.18bc
Hg [ng/g] Plasma 0.31 ±0.27 0.42 ±0.26 0.45 ±0.27
RBCs 0.37 ±0.30 0.47 ±0.34 0.46 ±0.28
Fe [μg/g] Plasma 1.33 ±0.41 1.86 ±0.97 1.83 ±0.85b
RBCs 196.84 ±29.93 149.02 ±36.91a 140.04 ±27.76b
The data are expressed as mean ± SD. P < 0.05 was accepted as significant (a – brain tumor vs. control, b – hydrocephalus vs. control, 
c – brain tumor vs. hydrocephalus).
Table II. Statistically significant correlations be-
tween biomarkers of oxidative stress, AChE activity, 
and metal concentrations in the plasma of patients 
with brain tumors and hydrocephalus
Investigated  
parameter
Metal 
ion
Brain tumor
r
Hydroceph-
alus
r
GST Mn  0.46
GST Co
GST Cu
GST Zn
GST As
GST Se
GST Cd
GST Fe  0.63
SH Co 0.47  0.79
SH Zn  0.62
SH Se
SH Cd 0.45
AChE Co –0.48
AChE Hg 0.51
Pearson’s correlation coefficients (r) with respect to single metal 
concentration. A minimum significance level of p < 0.05 was 
accepted.
Table III. Statistically significant correlations be-
tween biomarkers of oxidative stress, AChE activity, 
and metal concentrations in RBCs of patients with 
brain tumors and hydrocephalus
Investigated  
parameter
Metal 
ion
Brain tumor
r
Hydroceph-
alus
r
GST Mn  0.46
GST Co
GST Cu
GST Zn
GST As
GST Se
GST Cd
GST Fe  0.63
SH Co 0.47  0.79
SH Zn  0.62
SH Se
SH Cd 0.45
AChE Co –0.48
AChE Hg 0.51
Pearson’s correlation coefficients (r) with respect to single metal 
concentration. A minimum significance level of p < 0.05 was 
accepted.
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In our study, RBCs’ CuZn SOD activity was sig-
nificantly higher in both groups of patients com-
pared to the controls. The results of other authors 
show subnormal activities of SOD in tumors of 
the gastrointestinal tract multiple myeloma and 
endometrial cancer [26, 27]. A significant increase 
in CAT activity has been reported in various can-
cers such as gastric cancer [28] and carcinoma of 
the bladder [29]. Oxidative DNA damage in blood 
and other tissues was detected in various types 
of human carcinogenesis [30]. The GST is involved 
in detoxification of carcinogens and its activity 
increased significantly in cancer patients [31]. In 
smokers, the role of GST is crucial in modulating 
susceptibility to smoking-related lung cancer, oral 
cancer and chronic obstructive pulmonary disease 
[32]. It is also observed that GSH-Px and SOD ac-
tivities decrease in the cancer patients during can-
cer development [33]. 
Kudo et al. found significant differences in the 
GSH concentration between glioblastomas and 
astrocytomas [34]. Radiosensitive tumors, such as 
multiple myeloma, germinoma and small-cell car-
cinoma, showed low GSH concentrations. In our 
study, glutathione concentration was significantly 
higher in brain tumor and hydrocephalus patients 
than in control individuals. The higher activity of 
CuZn SOD and concentration of GSH compared 
to controls could indicate higher oxidative stress 
in both groups of patients. The GSH system plays 
a very important role in the brain’s defense. The 
GSH level was found to be significantly lower in 
glioblastomas compared to normal tissue and 
elevated only in meningioma [34]. A significant 
increase in all antioxidant enzyme activities and 
decrease in the GSH level were observed in some 
brain tumors [35]. 
Thiol-containing compounds such as SH groups 
are important components maintaining redox ho-
meostasis in cells, tissues and biological fluids in 
an organism. Modification of membrane proteins 
by SH groups changes membrane permeability. 
Oxidative modification of SH groups in enzymes 
or in their coenzymes exerts an influence on enzy-
matic activity. Metal ions bind to SH groups, and 
the intracellular fate of essential and non-essen-
tial metal ions strongly depends on the level of 
thiol-containing molecules [36]. Another import-
ant feature of SH groups is that they serve as a 
marker of protein oxidation [37]. In our experi-
ments, a significant decrease was noted in the 
concentration of SH groups. 
In order to detect possible differences between 
investigated groups, we employed principal com-
ponent analysis (PCA), which takes into account 
all the parameters examined. This analysis show 
clear separation between control individuals at 
the one hand, and patients with brain tumors and 
hydrocephalus on the other hand. At the same 
time, there is a clear separation between patients 
with brain tumors and hydrocephalus also. 
While Fe, Cu and Co undergo redox‐cycling re-
actions, for a second group of metal ions, Hg, Cd 
and Ni, the primary route for realization of their 
toxicity is depletion of glutathione and binding 
to sulfhydryl groups of proteins. Arsenic (As) is 
thought to bind directly to critical thiols. However, 
other mechanisms involving formation of hydro-
gen peroxide under physiological conditions have 
also been proposed [38].
In the study of Kuo et al. [39], Zn, Fe and Se con-
centrations were found to be significantly lower 
in cancer patients, while Cu concentrations were 
found to be either elevated or significantly ele-
vated when compared to age-matched samples 
of normal tissues. Transition metal ions such as 
Mn and Fe have been found to be present in sig-
nificantly lower concentrations in some tumors. 
Recent studies imply a low antioxidant status and 
enhanced oxidative stress in cancer patients, even 
before chemotherapy starts. 
High levels of oxidative stress result in peroxi-
dation of membrane lipids with the generation of 
peroxides that can decompose to multiple muta-
genic carbonyl products. Malondialdehyde (MDA) 
is a well-characterized lipid peroxidation end 
product. MDA is considered to be mutagenic and 
carcinogenic. The level of MDA reflects the extent 
of lipid peroxidation [40]. Elevated levels of lipid 
peroxidation products support the hypothesis that 
cancer cells produce a large amount of free radi-
cals and that there exists a relationship between 
free radical activity and malignancy [41]. In our 
study, there were no statistically significant differ-
ences in lipid peroxidation between the studied 
groups.
In our study a significant increase in AChE ac-
tivity was observed in hydrocephalus when com-
pared to both control and brain tumor groups. The 
absence of ChE inhibition could be a consequence 
of chronic contaminant exposure and of similar 
concentrations of most of the investigated metal 
ions. The ChE family includes acetylcholinesterase 
(AChE) and butyrylcholinesterase (BuChE), also 
known as pseudocholinesterase [42]. Cholines-
terases play an important role in nerve impulse 
transmission and are generally used as indicators 
of neurotoxicity [43]. There is evidence that heavy 
metal ions can alter ChE activities, and one of the 
possible mechanisms is through the ability of met-
al ions to cause diverse post-translational modifi-
cations of ChE proteins [44].
From  the presented results, it can be conclud-
ed that brain tumor and hydrocephalus patients 
have increased oxidative stress in the plasma 
and RBCs. The results of the present study sup-
port the concept of involvement of free radicals 
in the development of intracranial tumors and 
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hydrocephalus. Increases in the activity of CuZn 
SOD and GSH concentration, and decreases of 
CAT and GST activities, as well as concentration 
of SH groups, may be the major factors responsi-
ble for oxidative stress. In both groups of patients 
we observed decreased concentrations of Ni, Co, 
Zn and Fe (and Mn in brain tumor patients) and 
increased concentrations of As, Se and Cd in the 
blood. We also observed higher concentration of 
Cd in both plasma and RBCs of hydrocephalus pa-
tients compared to the patients with brain tumor. 
There is a strong correlation between some metal 
concentrations and certain oxidative stress bio-
markers in the blood of patients, which supports 
our hypothesis, but the observed trend should be 
further investigated. 
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